Tag: DepoVax

December 19, 2017

Top Biotech Stocks of 2017

Nearing the end of the year INN takes a look at the top gaining biotech stocks in the mid to...
July 4, 2017

5 Top Pharma Stocks on the TSX of Q2 2017

As investors look ahead at the remainder of 2017, INN put together a list of the top gaining pharmaceutical stocks...
April 18, 2017

Immunovaccine Begins Dosing on Clinical Trial

Immunovaccine announced the dosing of the first patient for their investigational cancer vaccine clinical study.
April 12, 2017

5 Top Pharma Stocks of Q1 2017 on the TSX

The Investing News Network takes a look at some of the best-performing pharmaceutical stocks on the TSX during the first...
April 12, 2017

Immunovaccine Shows Good Results from Clinical Trial

Immunovaccine provided new data from a Phase I trial testing safety and immunogenicity of its DepoVax-based, small B-cell epitope peptide...
April 5, 2017

Immunovaccine Shows Preclinical Research At Cancer Meeting

Immunovaccine (TSX:IMV, OTCQX:IMMVF) presented new preclinical data showcasing new options for its DepoVac-based therapeutic vaccine platform.
March 31, 2017

Immunovaccine Posts Financial Results For 2016

Immunovaccine (TSX:IMV, OTCQX:IMMVF) announced its financial and operational results for 2016.